Contact Form

Name

Email *

Message *

Cari Blog Ini

Delve Into The Science Behind The Edge Effect

The Braverman Test: Uncover Your Neurotransmitter Profile

Delve into the Science Behind the Edge Effect

The Braverman Test, introduced by Dr. Eric Braverman in his book "The Edge Effect," provides a comprehensive assessment of your neurotransmitter profile. This test helps you understand the strengths and imbalances of these neurochemicals, which play a crucial role in your mood, cognition, and overall well-being.

Instructions: Download and Complete the Test

To begin, download the Braverman Test in PDF format. The test consists of a series of questions designed to gauge your responses to various scenarios. Answer each question by circling either "T" for True or "F" for False. At the end of each group of questions, calculate your score by counting the number of "T" responses.

Interpreting Your Results

Once you have completed the test, consult the provided scoring key to determine the dominant and lesser dominant neurotransmitters in your brain. This information can provide valuable insights into your unique patterns of thought, behavior, and emotional responses.

Understanding Neurotransmitters

Neurotransmitters are chemical messengers that facilitate communication between neurons in your brain. The main neurotransmitters involved in the Braverman Test include:

  • Serotonin
  • Dopamine
  • Norepinephrine
  • Acetylcholine
  • GABA

Unveiling Your Neurochemical Landscape

By determining your neurotransmitter profile, you gain a deeper understanding of how your brain functions. This knowledge can empower you to make informed choices about your lifestyle, diet, and supplements to support your cognitive health and emotional well-being.

Disclaimer

It's important to note that the Braverman Test is not a diagnostic tool and should not be used as a substitute for professional medical advice. If you have concerns about your neurotransmitter balance, consult with a qualified healthcare practitioner for further evaluation and guidance.


Comments